期刊文献+

共刺激分子B7H3在结直肠癌血管中的表达及意义

下载PDF
导出
摘要 目的探讨共刺激分子B7H3在结直肠癌血管中的表达及意义。方法收集2013年5月至2016年5月结直肠癌手术切除标本60例,免疫组织化学法检测血管内皮生长因子(VEGF)和B7H3的表达,并分析其与临床病理间的关系。结果结直肠癌血管中B7H3阳性表达率显著高于癌旁组织血管(P〈0.05),同时VEGF在结直肠癌血管中阳性表达率亦显著高于癌旁组织血管(P〈0.05);B7H3在结直肠癌血管内皮细胞中的表达水平与患者性别、年龄、肿瘤位置、分化程度无相关性(P〉0.05),但与肿瘤Dukes分期密切相关(P〈0.05);在结直肠癌血管中B7H3和VEGF的表达呈正相关(r=0.60,P〈0.05)。结论B7H3在结直肠癌血管内皮细胞中存在高表达,其表达水平与肿瘤Dukes分期密切相关,血管中B7H3的表达可能与结直肠癌血管新生和肿瘤免疫逃逸密切相关。 Objective To explore the expression and clinical significances of co-stimulatory molecule B7H3 in the vessel endothelium of colorectal cancer. Methods 60 cases of colorectal patients were included in this experiment. The endothelial expression of VEGF and B7H3 were detected by immunohistochemistry. The correlations between B7H3 and the clinicopathological characteristics of CRC were also analyzed. Results The expressions of B7H3 and VEGF were significantly increased in CRC group compared to control group ( P〈0.05 ) . The endothelial expression of B7H3 was positively correlated with Dukes stage (P〈0.05) , but had no significant relations to the age, gender, tumour location and differentiation degree ( P〉0.05 ) . The endothelial expression of co-sfimulatory molecule B7H3 is positively correlated with VEGF ( r=0.60, P〈0.05 ) . Conclusion B7H3 was increased in the vessel endothelium of colorectal cancer. The endothelial expression of B7H3 is positively correlated with Dukes stage. B7H3 may be participated in the angiogenesis and immune escape process of colorectal cancer.
出处 《浙江临床医学》 2017年第11期2011-2013,共3页 Zhejiang Clinical Medical Journal
关键词 结直肠癌 B7H3 血管内皮生长因子 血管新生 肿瘤免疫逃逸 Colorectal cancer B7H3 Vascular endothelial growth factor Angiogenesis Tumor immune escape
  • 相关文献

参考文献3

二级参考文献21

  • 1Gupta K,Exp Cell Res,1999年,247卷,495页
  • 2Kim H, Kataru RP, Koh GY. Regulation and implications of inflammatory lymphangiogenesis [ J ]. Trends Immunol, 2012,33(7) :350-356.
  • 3Sheng KC, Wright MD, Apostolopoulos V. Inflammatory mediators hold the key to dendritie eell suppression and tumor progression [J]. Curt Med Chem,2011 ,18(36) :5507-5518.
  • 4Whiteside TI. Antitum or vaccines in head and neck cancer: targeting immune responses to the tumor [ J ]. Curt Cancer Drug Targets, 2007,7 ( 7 ) : 633-642.
  • 5Pinzon-Chatty A, Maxwell Lopez JA. Dendritic cell dysfunction in cancer: a mechanism for immunosuppression [ J ]. Immunol Cell Biol,2005,83 (5) :451-461.
  • 6Malhot L, Stenninger J. Behavior of seeds and soil in the mechanism of metastasis:a deeper understanding[ J ]. Cancer Sci, 2012,103 (4) :626-631.
  • 7Jemal A, Bray F,center MM,et al. Global cancer statistics[ J]. CA Cancer J Clin,2011,61 (2) :69-90.
  • 8Tie J, Desai J. Antiangiogenic therapies targeting the vascular endothelia growth factor signaling system [ J ]. Crit Rev Oncog, 2012,17( 1 ) :51-67.
  • 9Eichmann A, Simons M. VEGF signaling inside vascular endothelial cells and beyond [ J ]. Curr Opin Cell Biol, 2012,24 (2) :188-193.
  • 10Delirezh N, Moazzeni SM, Shokri F, et al. Autologous dendritic cells loaded with apoptotic tumor cells induce T cell mediated immune responses against breast cancer in vitro [ J ]. Cell Immuno1,2009,257 ( 1/2 ) :23-31.

共引文献32

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部